Processus de fermentation de l'insuline à haut rendement

• L'avenir des traitements du diabète

  Ce n’est que la pointe d’un avenir brillant que nous avons dans le domaine du diabète et il ne fera que s’améliorer à mesure que la technologie s’améliore et que de nouvelles idées nouvelles arrivent sur le marché. Cela pourrait permettre aux chercheurs de développer de nouvelles façons de traiter le diabète. Cela aiderait les personnes souffrant de diabète à mener une vie meilleure. Il leur serait plus facile de faire face à leur maladie et d'avoir une vie plus saine.

• Approches innovantes de la fermentation de l'insuline pour une efficacité accrue

  Parmi les nouveaux développements dans la synthèse de l’insuline, il y en a un passionnant qui implique certaines bactéries. Ce qui aide à produire de l’insuline beaucoup plus rapidement qu’auparavant grâce à l’aide de ces bactéries. Cette approche pourrait certainement révolutionner le traitement du diabète. Plus vite nous pouvons produire de l’insuline, plus les gens seront traités à temps avec ce dont ils ont réellement besoin.

• Le processus de fermentation à haut rendement

  Ils disposent également d'une nouvelle technique connue sous le nom de fermentation à haut rendement. Ce processus permet aux bactéries de produire encore plus d’insuline que d’habitude. Ce que nous appelons "les bactéries qui convertissent le sucre en insuline" peuvent augmenter le niveau d'insuline produite lorsque les circonstances s'améliorent. Puisque nous produisons beaucoup d'insuline en même temps, il est crucial d'en fabriquer d'ÉNORMES quantités afin de traiter tous les patients. .

Pourquoi choisir le processus de fermentation de l'insuline à haut rendement Yaohai ?

• Chaîne d’approvisionnement et capacités de fabrication robustes

  Yaohai Bio-Pharma, a top 10 High-Yield Insulin Fermentation Process of biological products, is a specialist in microbial fermentation. We have set up a modern facility that has robust RD capabilities and advanced infrastructure. Five lines of production for drugs conforming to GMP standards to purify and ferment microbial cells along with two fill and finish lines for vials as well as cartridges and needles pre-filled are readily available. The fermentation scales available for use range from 100L to 2000L. Filling specifications for vias are 1ml to 25ml, whereas pre-filled syringe or cartridge filling requirements are between 1-3ml. The production workshop is cGMP certified and offers the availability of commercial and clinical samples. The large molecules manufactured in our facility are available for delivery worldwide.

• Expertise professionnelle et vaste expérience

  Yaohai Bio-Pharma is a leading Microbial biologics CDMO. We have been focused on microbial-produced therapeutics and vaccines for human, veterinary, and the management of pet health. We are equipped with High-Yield Insulin Fermentation Process RD platforms as well as manufacturing technology that encompass the entire process beginning with the development of microbial strains cells, methods and processes, to commercial and clinical manufacturing which ensures successful implementation of cutting-edge solutions. We have acquired a large amount of experience in bio processing of microbial cells. We have delivered over 200 global projects, and help our clients with navigating the laws from the US FDA, EU EMA, Australia TGA, and China NMPA. Our professional expertise and extensive experience allows us to quickly respond to market demands and provide tailored CDMO services.

• Personnalisation, efficacité et rentabilité

  Yaohai Bio-Pharma is experienced in biologicals derived from microbial sources. We provide customized RD solutions and manufacturing, while minimising potential risks. We have worked on various modalities, including recombinant subunit vaccines, peptides hormones, cytokines growth factors, single-domain antibodies enzymes, plasmid DNA various mRNAs, and more. We have specialized in multiple microorganisms, including High-Yield Insulin Fermentation Process intracellular and extracellular secretion (yields up to 15g/L) and intracellular soluble bacteria and inclusion body (yields up to 10g/L). We have also established a BSL-2 fermentation platform to create bacteria-based vaccines. We are experts in improving processes, boosting product yields, and decreasing production costs. We have a highly efficient technology team that ensures timely and top-quality project delivery. This allows us to bring your unique products faster to market.

• Système qualité et conformité réglementaire mondiale

  Yaohai BioPharma is a Top 10 Microbial CDMO that integrates quality management and regulatory affairs. We have a quality management system that is in compliance with current High-Yield Insulin Fermentation Process and regulations around the globe. Our regulatory team is knowledgeable in the global regulatory frameworks that help accelerate biological launches. We ensure traceable production procedures quality products, as well as in compliance with the guidelines of the US FDA and EU EMA. Australia TGA and China NMPA are also in compliance. Yaohai BioPharma has successfully passed the on-site audit by the European Union's qualified Person (QP) for our GMP quality system and production site. We also successfully cleared the first certification audits of the ISO9001 Quality Management System and ISO14001 Environmental Management System.

Catégories de produits connexes

Vous ne trouvez pas ce que vous cherchez ?
Contactez nos conseillers pour plus de produits disponibles.